Ken Fisher's position in Sage Therapeutics is currently worth $8.22 Million. That's 0.00% of their equity portfolio (436th largest holding). The first Sage Therapeutics trade was made in Q3 2022. Since then Ken Fisher bought shares two more times and sold shares on three occasions. The investor's estimated purchase price is $16.3 Million, resulting in a loss of 49%.